In analytical chemistry, synthetic reference standards are often used to verify the identity of a molecule with certainty. However, in proteome research the generation or use of such standards is only beginning to be systematically implemented [2] [3] [4] . To facilitate this, we have embarked on a project termed ProteomeTools (Fig. 1) in which we aim to synthesize a library of ~1.4 million individ ual peptides to cover all human proteins (termed PROPEL, for ProteomeTools Peptide Library). Here, we report on our progress to date, presenting the synthesis and multimodal liquid chromato graphy-tandem MS (LCMS/MS) analysis of >330,000 synthetic tryptic peptides covering essentially all canonical human proteins as annotated in Swissprot.
Peptides were chosen based on either their experimentally determined proteotypicity 5, 6 or by brute force (all peptides within the typical mass range of a mass spectrometer) for hitherto unob served proteins and those with little prior experimental evidence. We also included a subset of peptides of the independently devel oped Human SRMAtlas 3 (Supplementary Table 1) , which focused on tryptic peptides, for collisioninduced dissociation and selected reaction monitoring (SRM) applications only. As more data on the use of alternative proteases become available 7 , such peptides (~300,000) will be systematically incorporated into the project to increase spectral and sequence coverage for any given protein.
Another 200,000 peptides are earmarked for protein sequence variants, such as protein isoforms or important natural or patho logical variants. An additional 350,000 peptides will be synthe sized to include posttranslational modifications (PTMs) such as phosphorylation, acetylation, methylation, ubiquitinylation and monoglycosylation 8 . While some of these peptides may be more challenging to synthesize, their impact will likely be high, as they reflect enzymatic activity that often modulates the function of proteins. Finally, we are reserving 200,000 peptides to represent other interesting biology, such as diseaseassociated mutations, HLA neoantigens, protease cleavage products, small open reading frames or translated long noncoding RNAs (lncRNAs) (Fig. 1a) .
Tryptic peptides were individually synthesized, combined into pools of ~1,000 peptides and spiked with 66 nonnaturally occur ring and 15 stableisotopelabeled peptides for retention time (RT) calibration. Whenever possible, we designed pools to avoid peptides of identical masses to prevent ambiguity in the MS data or to cover the entire LC gradient (Supplementary Fig. 1 ). Each pool was subjected to an initial LCMS/MS analysis using HCD and CID fragmentation on an Orbitrap Fusion Lumos mass spec trometer in order to assess successful peptide synthesis, to deter mine peptide chromatographic RTs and to compute RT indices (iRT; Supplementary Fig. 2 ) 9 . For each peptide pool, an inclusion building Proteometools based on a complete synthetic human proteome
We describe Proteometools, a project building molecular and digital tools from the human proteome to facilitate biomedical research. here we report the generation and multimodal liquid chromatography-tandem mass spectrometry analysis of >330,000 synthetic tryptic peptides representing essentially all canonical human gene products, and we exemplify the utility of these data in several applications. the resource (available at http://www.proteometools.org) will be extended to >1 million peptides, and all data will be shared with the community via Proteomicsdb and ProteomeXchange.
Proteomic research relies greatly on the mass spectrometric and bioinformatic analysis of proteolytic digests of complex protein mixtures to infer protein identity and quantity 1 . Although pow erful, there are technical and conceptual limitations that make the measurement of complete proteomes very challenging. These limitations are caused in part by the vast molecular complexity of proteomes that arises from-for example-gene expression, splic ing of mRNAs or posttranslational modification of proteins. As a result, the precise composition of a proteome is essentially always unknown. In addition, the measurement of proteasedigested proteomes by mass spectrometry (MS) creates large quantities of spectra of varying quality. The computational tools used in the field all make assumptions as to the presumed content of a proteome by matching mass spectra to peptides to infer proteins. The statistical methods applied invariably represent compromises in terms of the sensitivity and specificity with which proteins are identified from complex mixtures.
list was generated to target peptides for fragmentation in fur ther LCMS/MS experiments using five different fragmentation methods (HCD, CID, ETD, ETHCD and ETCID) with ion trap or Orbitrap readout; HCD spectra were recorded at six different collision energies (Supplementary Figs. 3-7) . Peptides ranged from 7 to 40 amino acids in length, and up to 96% of these pep tides could be detected by LCMS/MS in individual pools (78% average recovery; Supplementary Figs. 8 and 9) .
Using the open modification search option of MaxQuant/ Andromeda 10 , we assessed the side product profile to estimate the approximate yield of each peptide by measuring the percent age of the total MS signal that can be attributed to the target pep tide sequence (Fig. 1b and Supplementary Fig. 10 ). As expected, the purity of the synthesized peptides varied, and many of the chemical byproducts corresponded to incompletely removed protection groups or missing amino acids. The presence of byproducts turned out to be useful, as truncated peptides pro vided additional evidence for the presence of the correct full length peptide. In the future, these peptides may also serve to refine RT and fragmentation prediction or to identify some of the many goodquality spectra that remain unidentified in typical proteomic experiments 11 .
One important goal of ProteomeTools is to generate reference mass spectra (termed PROSPEC for ProteomeTools Spectrum Compendium) for the identification and quantification of human peptides and proteins. At an arbitrarily high Andromeda score cutoff of 100, indicating very high spectral quality, we obtained a total of 11.3 million peptide spectrum matches (PSMs) mapping to 211,895 peptides and covering each gene by a median of 9 pep tides (Fig. 1c) . The median precursor intensity fraction (PIF; i.e., the fraction of the precursor signal versus the total signal selected for fragmentation) was 92%, indicating that the spectra of most peptides are largely free of other contaminating peptides. Very highquality spectra were obtained for all 11 MS/MS methods used but with varying degrees of proteome coverage. Analysis of the Andromeda search engine score distribution (Fig. 1d) showed that the 211,895 peptides (peptide false discovery rate <0.002%) led to the identification of 19,735 of the 20,036 human genes deposited in Swissprot, thus providing very highquality reference spectra for 98.5% of the human proteome (Supplementary Table 2 and Supplementary Note 1). The remaining proteins often contain prolinerich repeats or homologous sequences that cannot be cov ered by unique tryptic peptides of reasonable length. Some of these may eventually be covered when synthesizing peptides using other digestion enzyme specificities. As an interesting side note, because of considerable protein sequence conservation between the human and mouse proteomes, the peptide library also contains 60,961 (proteotypic) peptides covering 12,599 (77%) unique mouse genes, thus considerably expanding the scope and utility of these peptides (Supplementary Table 3 and Supplementary Note 2).
One obvious use of synthetic peptide reference spectra is to confirm identifications of rarely (or newly) observed proteins. At the time of writing, there were only two spectra in ProteomicsDB supporting the identification of the same peptide of aquaporin 12B with identification Qscores different from the target-decoy distributions using the 'picked' target-decoy approach 12 (Fig. 2a) . The mirror plot showing the ion trap spectrum of the endogenous peptide and the corresponding spectrum of the synthetic peptide indicate very good agreement, thus validating the identification of this protein from a single peptide.
We recorded HCD spectra at six different normalized collision energies with the aim of identifying conditions for the measurement of peptides by targeted assays such as SRM, PRM or SWATH 13, 14 . To determine whether HCD spectra obtained in this study are suit able for this purpose, we compared our data to ~9,000 peptides from a SWATH spectral library built from proteome digests acquired on a QTOF instrument 15 . The analysis shows that there is very high correlation between the two types of data (R > 0.9) and that spectra with poor correlation may represent false positives in the SWATH spectral library ( Fig. 2b and Supplementary Fig. 11 ).
To illustrate the usefulness of the data for developing software, we built a prototype classifier based on multiple HCD spectra for the same peptide at a particular collision energy. This classifier predicts the fragment ion intensity of MS/MS spectra of any pep tide with Pearson correlation coefficients of around 0.9 ( Fig. 2c and Supplementary Figs. 12-14) . Such tools may complement or eventually replace experimental data for the development of SRM, PRM, or SWATH assays or facilitate the transfer of data recorded on a discovery proteomics instrument to an assay instrument. We consciously decided not to synthesize stableisotopeencoded peptides for this project because their fragmentation spectra can be easily simulated based on spectra of the unlabeled version. It is also more economically efficient to create heavy peptides tailored to the project at hand. However, we are in the process of measur ing peptides following chemical derivatization by tandem mass tags (TMT) and dimethyl labeling to cover the most commonly used stableisotope labeling methods.
An important aspect of the project is that it will enable and engage the proteomics community in a number of ways. We encourage the community to propose sets of peptides to include in the project. Our stocks contain 100 clones of the peptide library, which can be handed out to research groups willing to generate data on alternative mass spectrometric platforms such as QTOF instruments, ion mobility devices or different chromatographic systems. All of the current data are available in ProteomeXchange and ProteomicsDB 6, 16 , and we will provide all future data to enable reuse and reanalysis of what we believe is a valuable resource. The tryptic peptides reported here represent the beginning stages of the 3year ProteomeTools project (projected to finish at the end of 2018), and many further uses of the information generated can be envisaged. We plan to release new data every 6 months (~250,000 peptides per release) so that the community can access these data while the project progresses. The data should be valuable in the long term for the development of software tools that may include intelligent dataacquisition routines within the instrument control software 17 or the development of more pow erful database or spectral library search engines using, for exam ple, concepts of machine learning 18 . There is also still a need to develop improved statistical tools for the assessment of largescale proteomic experiments, particularly for dataindependent meas urements such as SRM, PRM, or SWATH. The spectral libraries we plan to generate should provide ample opportunity to facilitate these applications 19 . We also plan to build targeted assays in the next 2 years for sets of functionally important proteins, such as kinases and phosphopeptides representing the activation status of signaling pathways. We are confident that the molecular and digital tools arising from the ProteomeTools project will become valuable resources for the proteomics community. methods Methods, including statements of data availability and any associated accession codes and references, are available in the online version of the paper. 
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reprints and permissions information is available online at http://www.nature. com/reprints/index.html. online methods Synthetic peptide sets. To achieve extensive coverage of human proteins, three different sets of peptides were created or used in this study. First, a 'proteotypic' peptide set covering confidently and frequently identified proteins was derived from prior mass spectrometric evidence available in ProteomicsDB 5, 6 . We selected between two and ten unique (at gene level) tryptic peptides for each human gene to reach a cumulative proteotypicity of ~95% (i.e., we stopped selecting further peptides when the selected peptides covered at least 95% of all cases a particular protein was identified). Further constraints included a peptide length of 7 to 40 amino acids and no more than two missed tryptic cleavage sites. The resulting list contained 124,875 peptides covering 15,855 human Uniprot/SwissProt annotated genes. Second, a 'missing gene' set was constructed, which contained tryptic peptides map ping to genes which lacked confident experimental identification evidence in ProteomicsDB. Here, any geneunique tryptic peptide between 7 and 30 amino acids in length and allowing for a maxi mum of one missed cleavage site was included in the selection without restricting the number of peptides per gene. The resulting list contained 140,458 peptides covering 4,818 genes. Third, we obtained a subset of the 'SRMAtlas' peptides comprising 90,967 peptides mapping to 19,099 genes covering both proteins with empirical evidence as well as 'missing' proteins 3 . Altogether, the three sets of tryptic peptides contained 330,286 nonredundant peptides covering 19,840 human genes, as annotated in Uniprot/ SwissProt (Version 20160720; 42,164 protein sequences) (see Supplementary Table 1) .
Peptide pool design. Peptide pools for synthesis and LCMS/MS measurement consisted of approximately 1,000 peptides each. The peptide pools representing the 'proteotypic' and 'missing gene' sets were designed to have a narrow peptide length distri bution to support optimal synthesis by using a custom R script with the peptide sequence as input. Near isobaric peptides (±10 p.p.m.) were distributed across different pools of similar length to avoid ambiguous masses in pools wherever possible (Supplementary Table 1) . To this end, peptides were first ordered by length and mass. Second, the peptides were sorted by taking every n th peptide within the ordered list of peptides of one length, where n is the number of pools needed to distribute these pep tides. The resulting ordering provided a wellsampled subpopula tion of peptides with the same mass (MW) distribution. In a third step, peptides with near isobaric (±10 p.p.m.) mass were identified and, as long as no additional nearisobaric conflict was created, distributed across pools with similar peptide length (a maximum of three amino acids difference in length).
The SRMAtlas peptide set was acquired in 96well plates, with each well containing one individual proteotypic peptide of 7-30 amino acids in length (i.e., one peptide per well, PEPotec Grade 1, suspended in 0.1% TFA in 50% (v/v) acetonitrile/water). These were also pooled into sets of approximately 1,000 peptides. To create plate pools, the peptides from every plate were first manu ally pooled together, resulting in mixtures of 95 peptides (one qualitycontrol peptide present in each plate was discarded to avoid accumulation of this peptide in the subsequent pool ing process). To create measurement pools of ~1,000 peptides, either 10 (for fully tryptic peptides; i.e., Cterminal K/R) or 14 (nontryptic and semitryptic peptides; i.e., nonK/R Cterminal) plate pools were combined. In order to avoid bias in pools of 1,000 peptides regarding MW or hydrophobicity index (HI) 20 , the pooling scheme was computed to best mimic the overall MW and HI distribution of the entire set using a custom R script (all scripts available upon request). We used the Kolmogorov-Smirnov test (KS test) to quantify the distance of the MW and HI distribu tion between mixtures of plate pools to the total distribution of the total set. Starting with a plate pool or mixture of plate pools, all other (still available) plate pools were tested to generate a combined mixture that was closest to the overall set. The best match (lowest P value) was chosen, and the process was repeated until the desired number of plate pools for combination was reached (Supplementary Fig. 1 ). The resulting 96 measurement pools were desalted on C18 material (Waters, SepPak) before stor age at −20 °C. All peptide sequences and their pool membership are listed in Supplementary Table 1.
Peptide synthesis. All peptides were individually synthesized fol lowing the Fmocbased solidphase synthesis strategy. A carboxya midomethylated cysteine building block was used to eliminate the need for cysteine modification before MS analysis. Peptides of the 'proteotypic' and 'missing gene' sets were synthesized by SPOT synthesis on cellulose membranes at a scale of approximately 2-5 nmol of peptide per spot as described 21 . Depending on the length of peptides in a given pool, up to six peptide pools (con taining at most 6,000 peptides; see Supplementary Note 1) were synthesized in parallel using a purposebuilt peptide synthesizer. Five qualitycontrol peptides were synthesized along with every peptide pool. Peptides were cleaved from the membrane into pools of 1,000 peptides following the design criteria described above. Following solvent evaporation, peptides were stored at −20 °C until use. Peptides from the SRMAtlas set were synthesized in 96well synthesizers (Thermo Fisher Scientific, PEPotec Grade 1) at a scale of 0.1 mg per peptide. They were pooled and stored as described above.
Sample preparation for mass spectrometry. Dried peptide pools were initially solubilized in 100% DMSO to a concentration of 10 pmol/µl by vortexing for 30 min at room temperature. The pools were then diluted to 10% DMSO using 1% formic acid in HPLCgrade water to a stock solution concentration of 1 pmol/µl and stored at −20 °C until use. 10 µl of the stock solution was transferred to a 96well plate and spiked with two retention time (RT) standards. The first set of RT peptides (JPT Peptide Technologies) consisted of 66 peptides with nonnaturally occur ring peptide sequences (Supplementary Table 1) . 200 fmol per peptide was used per injection. The second RT standard (Pierce, Thermo Scientific) comprised 15 13 Clabeled pep tides, and 100 fmol per peptide was used per injection. Samples in the resulting 96well plates were vacuum dried and stored at −20 °C until use.
Nanoscale liquid chromatography. For LCMS/MS analysis, the peptide pools in the 96 well plates were dissolved in 0.1% formic acid in water to a concentration of 100 fmol/µl per peptide (residual DMSO concentration of ~1%). An estimated amount of 200 fmol of every peptide in a pool was subjected to liquid chromatography using a Dionex 3000 HPLC system (Thermo Fisher Scientific) using inhouse packed C18 columns. The setup consisted of a 75 µm × 2 cm trap column packed with 5 µm particles of Reprosil Pur ODS3 (Dr. Maisch GmbH) and a 75 µm × 40 cm analytical column packed with 3 µm particles of C18 Reprosil Gold 120 (Dr. Maisch GmbH). Peptides were loaded onto the trap column using 0.1% FA in water. Separation of the peptides was performed by using a linear gradient from 4% to 35% ACN with 5% DMSO, 0.1% formic acid in water over 50 min followed by a washing step (60 min total method length) at a flow rate of 300 nL/min and a column temperature of 50 °C.
Mass spectrometry. The HPLC system was coupled online to an Orbitrap Fusion Lumos mass spectrometer (Thermo Fisher Scientific). Each peptide pool was first measured using a 'survey method' consisting of an Orbitrap full MS scan (60,000 resolution, 5 × 10 5 AGC target, 50 ms maximum injection time, 360-1,300 m/z, profile mode), followed by MS2 events with a duty cycle of 2 s for the most intense precursors and a dynamic exclusion set to 5 s as follows: (i) HCD scan with 28% normalized collision energy and Orbitrap readout (15,000 resolution, 1 × 10 5 AGC target, 22 ms maximum injection time, inject ions for all available paral lelizable time enabled, 1.3 m/z isolation width, centroid mode); (ii) CID scan with 35% normalized collision energy and ion trap readout (rapid mode, 3 × 10 4 AGC target, 0.25 activation Q, 22 ms maximum injection time, inject ions for all available parallelizable time enabled, 1.3 m/z isolation width, centroid mode). From these data, inclusion lists with RT constraints were generated for each pool and used for three subsequent LCMS/MS measurements focusing on different acquisition types. Precursors detected in the survey method were scheduled for fragmentation within a ±5 min RT window. Peptides lacking identification in the survey run were added to the inclusion as 2 + or 3 + precursor ions, but without RT scheduling. HCD activation with 28% normalized collision energy and Orbitrap readout; (iii) ETciD scan using chargedepend ent ETD parameters and supplemental CID activation with 35 normalized collision energy and Orbitrap readout with settings described above.
Data processing. The logistics of data processing and MS method generation were governed by an inhouse database (Supplementary Fig. 8 ). RAW data were analyzed using MaxQuant version 1.5.3.30 searching individual LCMS/MS runs against poolspecific databases (see Supplementary Table 2 ) 23 .
If not mentioned otherwise, default parameters were used: car bamidomethylated cysteine was specified as fixed modification, methionine oxidation as variable modification. First search tolerance was set to 20 p.p.m., main search tolerance to 4.5 p.p.m. and filtered for peptide and protein false discovery rate of 1%. RT windows of ±5 min were corrected for drifts using the internal RT standards. The poolspecific inclusion lists were generated from confidently identified precursors (from the survey method) which passed an ad hoc Andromeda score cutoff of 100. For analysis of synthesis side product, the survey MS run was searched with unspecific digestion and 'dependent peptides' enabled.
Conserved peptide sequences in human and mouse. A current mouse protein sequence database representing 16,336 mouse genes was obtained from Swissprot (version dated 07/09/2016; 16,818 sequences). The database was in silico digested using tryp tic cleavage specificity (no proline rule) and a maximum of two missed cleavages. The resulting peptide list was filtered for unique entries and mapped against our sequence list of peptides (see Supplementary Note 2 and Supplementary Table 3) .
Comparison QTOF versus Fusion Lumos spectra. We systemati cally compared spectra generated in this project on an Orbitrap Fusion Lumos (Thermo) to a spectral library generated on a 5600 TripleTOF (QTOF) mass spectrometer (AB Sciex) 15 . For this, intensities of matching annotated fragment ions of the highest scoring (>100) beamtype CID spectrum per acquired normal ized collision energy (Lumos) were correlated using Pearson cor relation to the corresponding beamtype CID QTOF spectrum (acquired with rolling collision energy). Comparison was per formed using a custom R script that used the MaxQuant output files as well as the QTOF spectral library as input.
Fragmentation prediction. First, MaxQuant result files were parsed using a custom R script, and only spectra of unmodified doubly charged peptides with a PIF > 0.8 and a score of higher than 100 were selected for training. For each combination of amino acids Nterminal (left) and Cterminal (right) of the fragmentation position at a given normalized collision energy, a local polynomial regression (LOESS) model was fitted using the peptide length normalized fragmentation position, and the base peak intensity (BPI) normalized intensity of the yions (see Supplementary Figs. 11-13) . The resulting models were tested on pool 66 of the proteotypic set using the same peptide selection criteria. Each possible yion for each peptide passing the filters was predicted using the corresponding LOESS fit. The predicted yion intensities were scored against the measured spectra using the Pearson correlation coefficient. 
